Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Walter Liszewski , MD

Dermatology โ€ข Chicago, IL

Active NPI 1033505243 Individual Practitioner Male Practitioner Accepts Medicare assignment Telehealth (some services)
Practice location in NPPES

676 N Saint Clair St Ste 1600
Chicago, IL 606112997

Call 3126958106 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

676 N Saint Clair St Ste 1600

Chicago, IL 606112997

Telephone 3126958106
Other Listings in Public Data

NPPES lists 3 distinct additional practice-address records in New Orleans, LA; Saint Paul, MN; St Louis Park, MN. See the list

Source: CMS NPPES NPI Registry, practice location records; release date unavailable.

CMS Doctors and Clinicians lists 1 group name: Northwestern Medical Faculty Foundation. See the list

Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File

Medical School

Tulane University School Of Medicine

Graduation Year

2015

Medicare patients

449 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners โ€“ by Provider, 2024.

Medicare-allowed amount

About $130,560 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners โ€“ by Provider and Service, 2024.

Paid by Medicare

About $92,447 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners โ€“ by Provider and Service, 2024.

30-day fills

982 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$782,554 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers โ€“ by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $303,912.37 across 234 records.

By nature of payment (3 largest of 4)

  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $218,470.00 across 58 records.
  • Consulting Fee: $60,451.25 across 18 records.
  • Travel and Lodging: $18,898.97 across 55 records.

Reporting-company totals (3 largest of 14)

  • Eli Lilly and Company: $100,390.57 across 75 records.
  • Sanofi and Genzyme US Companies: $84,968.22 across 35 records.
  • Galderma Laboratories, L.P.: $54,016.50 across 46 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

11 years (graduated 2015)

CMS Doctors and Clinicians data list 2015 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File.

NPI first issued

2015

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians; Medicare.gov, โ€œDoes your provider accept Medicare as full payment?โ€

Guide: What Medicare assignment means

Telehealth (some services)

Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.

What this does not show: Telehealth (some services)

It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Liszewski has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Liszewski as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Chicago and Illinois

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 95% of clinicians listed under Dermatology in Chicago, IL (2024, 113 clinicians with data). Median for this group: 734. Middle half: 298 to 1,752.

More Medicare Part B services than 80% of clinicians listed under Dermatology in Illinois (2024, 405 clinicians with data). Median for this group: 2,033. Middle half: 899 to 4,119.

Medicare-allowed amount

A higher Medicare-allowed amount than 75% of clinicians listed under Dermatology in Chicago, IL (2024, 113 clinicians with data). Median for this group: $55,579. Middle half: $21,156 to $115,126.

Close to the middle for clinicians listed under Dermatology in Illinois (2024, 405 clinicians with data). Median for this group: $141,868. Middle half: $64,155 to $281,967.

Paid by Medicare

A higher Medicare payment amount than 75% of clinicians listed under Dermatology in Chicago, IL (2024, 113 clinicians with data). Median for this group: $38,442. Middle half: $14,571 to $82,347.

Close to the middle for clinicians listed under Dermatology in Illinois (2024, 405 clinicians with data). Median for this group: $99,602. Middle half: $44,437 to $204,261.

Medicare Part D prescriptions

More Part D prescriptions than 85% of clinicians listed under Dermatology in Chicago, IL (2024, 146 clinicians with data). Median for this group: 223. Middle half: 94 to 508.

More Part D prescriptions than 65% of clinicians listed under Dermatology in Illinois (2024, 468 clinicians with data). Median for this group: 471. Middle half: 165 to 904.

Part D drug cost

A higher Part D drug cost than 95% of clinicians listed under Dermatology in Chicago, IL (2024, 146 clinicians with data). Median for this group: $50,146. Middle half: $2,705 to $189,548.

A higher Part D drug cost than 90% of clinicians listed under Dermatology in Illinois (2024, 468 clinicians with data). Median for this group: $69,576. Middle half: $5,709 to $275,598.

233 active clinicians are listed under Dermatology with a practice address in Chicago, IL (647 in Illinois).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Chicago

10.3% of these 233 clinicians have the CMS telehealth indicator.

54.9% of these 233 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo ยท Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments ยท Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 โ€“ December 31, 2025): 234 records totaling $303,912.37.

Manufacturer Payment Nature Product Type Amount ($)
Sanofi and Genzyme US Companies
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $11,938.00
Sanofi and Genzyme US Companies
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $11,938.00
Sanofi and Genzyme US Companies
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $11,938.00
Galderma Laboratories, L.P.
Consulting Fee
Cash or cash equivalent
NEMLUVIO General $11,475.00
Sanofi and Genzyme US Companies
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $10,028.00
Sanofi and Genzyme US Companies
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $10,028.00
Galderma Laboratories, L.P.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
NEMLUVIO General $9,800.00
Novartis Pharmaceuticals Corporation
Consulting Fee
Cash or cash equivalent
โ€” General $8,000.00
Eli Lilly and Company
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EBGLYSS General $6,400.00
Sanofi and Genzyme US Companies
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $5,253.00
Galderma Laboratories, L.P.
Consulting Fee
Cash or cash equivalent
NEMLUVIO General $5,100.00
ABBVIE INC.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RINVOQ General $4,900.00
Sanofi and Genzyme US Companies
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $4,775.00
Arcutis Biotherapeutics, Inc.
Consulting Fee
Cash or cash equivalent
Zoryve General $4,500.00
Sanofi and Genzyme US Companies
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $4,340.00
Sanofi and Genzyme US Companies
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $4,298.00
Sanofi and Genzyme US Companies
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $4,298.00
LEO Pharma Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
ANZUPGO General $4,073.00
Regeneron Pharmaceuticals, Inc.
Consulting Fee
Cash or cash equivalent
DUPIXENT General $3,820.00
Galderma Laboratories, L.P.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
NEMLUVIO General $3,600.00
Galderma Laboratories, L.P.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
NEMLUVIO General $3,600.00
Galderma Laboratories, L.P.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
โ€” General $3,600.00
ABBVIE INC.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RINVOQ General $3,500.00
LEO Pharma Inc.
Consulting Fee
Cash or cash equivalent
ANZUPGO General $3,500.00
Kowa Pharmaceuticals America, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
ZORYVE General $3,375.00

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B ยท Data Year 2024
Reporting Year:

CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2018โ€“2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ€“ by Provider and Service data, 2019โ€“2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
95044 Test for allergy using skin patch
3,730 43 $26.00 $5.48
96900 Application of ultraviolet light to skin
544 17 $107.00 $26.19
17003 Destruction of precancer skin growth, 2-14 growths
334 76 $46.00 $6.87
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
251 195 $323.00 $135.62
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
184 157 $218.32 $96.65
17000 Destruction of precancer skin growth, 1 growth
131 115 $259.00 $59.77
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
71 71 $505.00 $175.21
11102 Biopsy of related skin growth, first growth
68 62 $363.00 $102.09
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
37 37 $330.00 $119.62
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
36 33 $88.00 $17.45
17110 Destruction of skin growth, 1-14 growths
30 25 $353.00 $116.08
11103 Biopsy of related skin growth, each additional growth
20 15 $153.00 $53.36
11104 Punch biopsy, first skin growth
14 14 $363.00 $132.77
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
13 13 $434.00 $181.46
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
12 12 $132.00 $59.99

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D ยท Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Ketoconazole Ketoconazole 173 4,677 $2,888.52 94
Triamcinolone Acetonide Triamcinolone Acetonide 149 4,576 $1,683.75 109
Minoxidil Minoxidil 61 5,044 $398.61 21
Clobetasol Propionate Clobetasol Propionate 54 1,394 $2,204.14 28
Ciclopirox Ciclopirox 39 1,125 $1,176.09 17
Tacrolimus Tacrolimus 36 844 $5,550.94 23
Dupixent Pen Dupilumab 32 882 $116,818.27 โ€”
Dupixent Syringe Dupilumab 27 756 $96,793.92 โ€”
Clindamycin Phosphate Clindamycin Phosphate 21 695 $699.26 โ€”
Hydrocortisone Hydrocortisone 19 304 $135.37 15
Metronidazole Metronidazole 18 425 $665.93 โ€”
Methotrexate Methotrexate Sodium 18 980 $497.22 โ€”
Doxycycline Monohydrate Doxycycline Monohydrate 17 544 $288.56 14
Terbinafine Hcl Terbinafine Hcl 15 591 $138.89 โ€”
Desonide Desonide 14 366 $952.12 โ€”
Fluorouracil Fluorouracil 14 421 $1,619.17 12
Humira(Cf) Adalimumab 13 364 $84,594.38 โ€”
Fluocinonide Fluocinonide 12 370 $412.35 12
Skyrizi Pen Risankizumab-Rzaa 12 896 $242,026.02 โ€”
Nystatin Nystatin 11 375 $179.47 โ€”
Tretinoin Tretinoin 11 370 $373.34 โ€”
Otezla Apremilast 11 330 $62,071.84 โ€”
Cosentyx Sensoready Pen Secukinumab 11 308 $160,385.94 โ€”

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Dermatology Primary Specialty

NUCC Taxonomy Code: 207N00000X

License # reported to NPPES IL 036.149833

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

Dermatology

NUCC Taxonomy Code: 207N00000X

License # reported to NPPES MN 62406

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

Student in an Organized Health Care Education/Training Program

NUCC Taxonomy Code: 390200000X

An individual who is enrolled in an organized health care education/training program leading to a degree, certification, registration, and/or licensure to provide health care.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Illinois Department of Financial and Professional Regulation.
Look Up on State Board Site

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - DERMATOLOGY

Medicare Enrollment ID

I20190808001792

Enrollment State Jurisdiction

IL

PECOS Control ID

5496040958

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File

Northwestern Medical Faculty Foundation

676 N St Clair, Chicago, IL 606112997

Phone: 3126958106

Secondary Practice Locations

7918 Sycamore St

New Orleans, LA 70118

Phone: 5043447620

3800 Park Nicollet Blvd

St Louis Park, MN 554162527

Phone: 9529933123

1021 Bandana Blvd E Ste 100

Saint Paul, MN 55108

Phone: 6122625000

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

25 listed
Alexander Blank , PA-C

Physician Assistant

NPI 1356961015

Physician Assistant (Certified)

NPI 1003875741

Doctor of Medicine (M.D.)

Dr. Lu Chen , MD

Dermatology

NPI 1124445077

Doctor of Medicine (M.D.)

NPI 1689856049

Doctor of Medicine (M.D.), Doctor of Philosophy (Ph.D.)

NPI 1598931719

Doctor of Medicine (M.D.)

NPI 1851656516

Doctor of Medicine (M.D.)

Career & Practice History Timeline

Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status

16 Historical Events
๐Ÿ“
Updated Practice Location July 29, 2019

Registered at 676 N SAINT CLAIR ST STE 1600, CHICAGO, IL 606112997 (Tel: 3126958106)

๐Ÿ“
Updated Business Mailing Address July 29, 2019

Registered at 676 N SAINT CLAIR ST STE 1600, CHICAGO, IL 606112997 (Tel: 3126958106)

๐Ÿ‘ค
Provider Name / Credentials Updated July 29, 2019

Recorded as WALTER LISZEWSKI, MD

๐ŸŽ“
Medical Taxonomy / Specialty Registered (Primary Specialty) July 29, 2019

Dermatology (license number reported to NPPES: IL 036.149833)

๐Ÿ“
Updated Practice Location August 08, 2018

Registered at 1021 BANDANA BLVD E STE 100, SAINT PAUL, MN 55108 (Tel: 6122625000)

โœ…
NPI Profile Active August 28, 2017

NPI status registered as active in NPPES database

๐Ÿ“
Updated Practice Location August 28, 2017

Registered at 1021 BANDANA BLVD E STE 100, SAINT PAUL, MN 551085109 (Tel: 6122625000)

๐Ÿ“
Updated Business Mailing Address August 28, 2017

Registered at 7918 SYCAMORE ST, NEW ORLEANS, LA 70118 (Tel: (504) 344-7620)

๐Ÿ‘ค
Provider Name / Credentials Updated August 28, 2017

Recorded as WALTER LISZEWSKI

๐ŸŽ“
Medical Taxonomy / Specialty Registered (Primary Specialty) August 28, 2017

Student in an Organized Health Care Education/Training Program

โœ…
NPI Profile Active April 14, 2015

NPI status registered as active in NPPES database

๐Ÿ“
Practice Location (Initial Record) April 14, 2015

Registered at 7918 SYCAMORE ST, NEW ORLEANS, LA 70118 (Tel: 5043447620)

๐Ÿ“
Business Mailing Address (Initial Record) April 14, 2015

Registered at 7918 SYCAMORE ST, NEW ORLEANS, LA 70118 (Tel: 5043447620)

๐Ÿ‘ค
Provider Name / Credentials (Initial Record) April 14, 2015

Recorded as WALTER LISZEWSKI

๐ŸŽ“
Medical Taxonomy / Specialty Registered (Primary Specialty) April 14, 2015

Student in an Organized Health Care Education/Training Program

๐ŸŸข
Initial NPI Registration & Enumeration April 14, 2015

First registered as active Individual Practitioner in NPPES Database.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1033505243
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: April 14, 2015
Last Update: July 29, 2019
Sole Proprietor: No

Other Dermatology Specialists in Chicago

All Dermatology Specialists in Chicago

More public profiles in Illinois

Directory navigation, in NPI number order.

Mailing Address

676 N Saint Clair St Ste 1600

Chicago, IL 606112997

Phone: 3126958106

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.